chevron_leftBack
As of 14 June 2026, Cachet Pharmaceutical Co., Ltd. has a market cap of $601.41M USD, ranking #13943 globally and #4283 in China.
It ranks #1247 in the Healthcare sector, and #462 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$601.41MUSD
4.08B CNY
Enterprise Value
$733.72MUSD
4.97B CNY
Revenue (TTM)
$2.88BUSD
19.53B CNY
EBITDA (TTM)
$58.88MUSD
398.49M CNY
Net Income (TTM)
$16.44MUSD
111.38M CNY
EBITDA Margin
2%
Profit Margin
0.6%
PE Ratio
36.8
PS Ratio
0.2
PB Ratio
0.7
EV/EBITDA
10.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Yibin Huang
open_in_new
Employees
1,969
Founded
1997
Website
cachet.com.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.2% | -0.4% | -3.1% | -15% | -11% | 16% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002462
嘉事堂药业股份有限公司 Class A
ISIN: CNE100000SN0
Shares Out.:
Shares Outstanding:
291.707M1
Shares Float:
242.684M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
13.80 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Cachet Pharmaceutical Co., Ltd.
Cachet Pharmaceutical Co., Ltd. engages in the wholesale, retail, and logistics of pharmaceutical products in China. The company also offers medical drugs, medical devices, e-commerce products, and warehousing logistics services. It sells its products through online and offline channels. The company was founded in 1997 and is headquartered in Beijing, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
9K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
8K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
5K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
3K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
3K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
3K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
127K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
91K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
60K%
|
97.4
|
|
SIX: RO
|
$321.52B
53K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
48K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
46K%
218.9B CHF
|
20.5
|
chevron_leftBack